Prevalence of type-specific HPV infection by age and grade of cervical cytology: data from the ARTISTIC trial - Wikidata - wikimedia - TriplyDB

Prevalence of type-specific HPV infection by age and grade of cervical cytology: data from the ARTISTIC trial

Prevalence of type-specific HPV infection by age and grade of cervical cytology: data from the ARTISTIC trial

http://www.wikidata.org/entity/Q31151637

about

Surgery for cervical intraepithelial neoplasia Interventions for preventing blood loss during the treatment of cervical intraepithelial neoplasia Surgery for cervical intraepithelial neoplasia Interventions for preventing blood loss during the treatment of cervical intraepithelial neoplasia Are the Two Human Papillomavirus Vaccines Really Similar? A Systematic Review of Available Evidence: Efficacy of the Two Vaccines against HPV Prevalence of human papillomavirus in women attending cervical screening in the UK and Ireland: new data from northern Ireland and a systematic review and meta-analysis.Clinical impact of the analytical specificity of the hybrid capture 2 test: data from the New Technologies for Cervical Cancer (NTCC) study Type-specific prevalence of high-risk human papillomavirus by cervical cytology and age: Data from the health check-ups of 7,014 Korean women.Optimal threshold for a positive hybrid capture 2 test for detection of human papillomavirus: data from the ARTISTIC trial.Cervical cytology and multiple type HPV infection: a study of 8182 women ages 31-65 Predicted impact of vaccination against human papillomavirus 16/18 on cancer incidence and cervical abnormalities in women aged 20-29 in the UK.Population-based type-specific prevalence of high-risk human papillomavirus infection in Estonia.Cervical HPV type-specific pre-vaccination prevalence and age distribution in Croatia.Cervical human papillomavirus infection in a sample of Hispanic women living in Puerto Rico: comparison with cervical cytology reports.Prevalence of high-risk HPV types and associated genital diseases in women born in 1988/89 or 1983/84--results of WOLVES, a population-based epidemiological study in Wolfsburg, Germany.HPV16 early gene E5 specifically reduces miRNA-196a in cervical cancer cells.Clinical experience with the Cervista HPV HR assay: correlation of cytology and HPV status from 56,501 specimens Comparison of the cobas Human Papillomavirus (HPV) test with the hybrid capture 2 and linear array HPV DNA tests.Cervical cancer incidence in young women: a historical and geographic controlled UK regional population study.Frequency and risk factors for prevalent, incident, and persistent genital carcinogenic human papillomavirus infection in sexually active women: community based cohort study Cross-reactivity profiles of hybrid capture II, cobas, and APTIMA human papillomavirus assays: split-sample study Practice guidelines for the early detection of cervical cancer in Korea: Korean Society of Gynecologic Oncology and the Korean Society for Cytopathology 2012 edition.Human papillomavirus genotype specificity of hybrid capture 2 Characteristics and screening history of women diagnosed with cervical cancer aged 20-29 years.Human papillomavirus prevalence in women attending routine cervical screening in South Wales, UK: a cross-sectional study High prevalence and incidence of human papillomavirus in a cohort of healthy young African female subjects Human papillomavirus genotype distributions: implications for vaccination and cancer screening in the United States.The impact of human papillomavirus vaccination on cervical cancer prevention efforts.Age-specific prevalence of HPV genotypes in cervical cytology samples with equivocal or low-grade lesions.Human papillomavirus types distribution in organised cervical cancer screening in France.Multiple-type human papillomavirus (HPV) infections: a cross-sectional analysis of the prevalence of specific types in 309,000 women referred for HPV testing at the time of cervical cytology.Does HPV type 16 or 18 prevalence in cervical intraepithelial neoplasia grade 3 lesions vary by age? An important issue for postvaccination surveillance.An overview of early investigational drugs for the treatment of human papilloma virus infection and associated dysplasia.Negative computer-imaged ThinPrep Pap test and positive hybrid capture2 HPV co-testing results: A quality assurance review.Community-Based Prevalence of Genital Human Papilloma Virus (HPV) Infection: a Systematic Review and Meta-Analysis Comparison Between Two Detection Methods for HPV16, HPV18 and P16Ink4a Biomarkers in Diagnosis of Abnormal Cervical Cytology Human papillomavirus infections in Mexican women with normal cytology, precancerous lesions, and cervical cancer: type-specific prevalence and HPV coinfections.Potential coverage of circulating HPV types by current and developing vaccines in a group of women in Bosnia and Herzegovina with abnormal Pap smears.Long-term HPV type-specific risks of high-grade cervical intraepithelial lesions: a 14-year follow-up of a randomized primary HPV screening trial.Carcinogenic HPV prevalence and age-specific type distribution in 40,382 women with normal cervical cytology, ASCUS/LSIL, HSIL, or cervical cancer: what is the potential for prevention?

P2860

Q24201956-B9A761F2-9FE9-406C-A1A8-0EEEA8D16713 Q24201965-704694FF-B959-4681-9D62-B5F7ACCD244C Q24234819-A022353E-56DD-4F84-A60C-CA59AF42DEA4 Q24234957-45423B3F-D08C-4590-ACA2-3392EFA35F3A Q26783973-22294002-76BF-4B28-9EE9-8CD920F719E3 Q30577846-AC1B72C8-D4D6-415F-A385-2F5B5AE11CF2 Q30651813-E842E6F1-3D22-43C1-AB10-3A7CDC3F0BF6 Q30712681-9C81F03B-FF98-46E4-AFC4-6C126EFB1E2D Q33518244-10A690D1-7B42-4AF8-AA8E-8D9E6264C7C6 Q33693366-403DF631-E98E-4C90-8C1D-4862A48CBE8E Q33708098-E4D4F3D2-C3FC-4252-8C2D-EFEBDC8B78CD Q33737295-6A9A3EE3-99BA-4EBA-8233-8D5D3FB67C9D Q33888215-6911D349-661F-4C4F-84EB-E61A97993126 Q34171516-7E202BB9-4DD4-4F80-AB37-9B5A84FF9043 Q34622565-D29C2283-D159-4F4A-9044-CCE2A0CDA3B6 Q34883792-640B6430-5A0B-49C1-B601-6C135EFD63C3 Q35083587-A27E64D2-8729-489B-BBB7-148A33C614FA Q35668232-CFF103A1-B81B-489B-809D-378746C41E31 Q35998455-DA203874-2AD5-4BC4-86F2-2181FB290D24 Q36055770-397E520B-072C-4257-9645-5600E2018EE9 Q36083187-71EA8B86-B4DE-4EFF-8E08-EBEA2AF75798 Q36817519-A3BA2507-C05A-4E6C-A104-35B34BBEFA8C Q36845399-F4EC3AE5-40FA-497B-B4A7-F3E0499C6340 Q37003411-B3BC074F-918C-427A-A57E-F7C7831EEAD9 Q37010572-160771C3-BDC7-4864-8ACD-5038AC3258A2 Q37030821-C89E4268-5619-48FB-8E11-F444F72296D3 Q37147012-398D7937-9570-4EE0-8001-0E5450CFFF61 Q37245134-BFC82E2F-3B1A-4C5D-B371-F0FBFB52BCEC Q37287526-177DB3CF-6041-4679-9AAD-4A3D32267265 Q37309275-3B36F744-9828-4FF8-9511-5CC0DE1D3EE5 Q37438579-B11EB367-4BA1-4F2D-AB92-9E1761B0F1AB Q37983132-D8918DEA-86E1-4FB2-90F2-A43413450F95 Q38386055-D3A48D6F-DD9E-4353-8A7F-80B58CC4C8C7 Q38546938-1742BA44-00BC-4F5D-A09A-813965909C77 Q38940138-AA7616BE-1182-42D7-81BA-C74E543FF393 Q40357072-AFF31AA9-0B5F-4ADA-962F-CDF7603DD211 Q41465634-9BF2E1AB-51CB-46A3-8A57-ADD009E420BC Q41551110-4D007276-95D9-49D2-8404-65D5AB020534 Q42204957-ADD83A77-DBDA-47C5-8D85-2FC43EB0E7A6 Q42255129-3BB98EF6-0890-4BE1-B842-36882615CAE7

P2860

Prevalence of type-specific HPV infection by age and grade of cervical cytology: data from the ARTISTIC trial

http://www.wikidata.org/entity/Q31151637

description

2008 nî lūn-bûn

@nan

2008 թուականի Ապրիլին հրատարակուած գիտական յօդուած

@hyw

2008 թվականի ապրիլին հրատարակված գիտական հոդված

@hy

2008年の論文

@ja

2008年論文

@yue

2008年論文

@zh-hant

2008年論文

@zh-hk

2008年論文

@zh-mo

2008年論文

@zh-tw

2008年论文

@wuu

name

Prevalence of type-specific HP ...... : data from the ARTISTIC trial

@ast

Prevalence of type-specific HP ...... : data from the ARTISTIC trial

@en

type

label

Prevalence of type-specific HP ...... : data from the ARTISTIC trial

@ast

Prevalence of type-specific HP ...... : data from the ARTISTIC trial

@en

prefLabel

Prevalence of type-specific HP ...... : data from the ARTISTIC trial

@ast

Prevalence of type-specific HP ...... : data from the ARTISTIC trial

@en

P1433

Q31151637-DC8F5E07-779A-46AB-A161-F7B5D4AE3DE0

P1476

Q31151637-5ED104FE-C5AC-4C73-9B56-0052735C1A2C

P2093

Q31151637-0BD08022-D874-4F15-8029-8E19FCF68184

Q31151637-1F12EA92-7560-4DAF-9EBB-45282098A830

Q31151637-25929BB4-73C0-4D33-8163-1F6FC1E74AB5

Q31151637-376028D2-41C4-4B42-8F84-B3AC646E5376

Q31151637-60A0CD69-3D39-4855-81FA-CEDD259010AD

Q31151637-6A32F2C8-3460-407C-B426-C2C81C7C0531

Q31151637-6BFDA17D-25EE-4BA8-8B9B-73622CD4595A

Q31151637-7AA82347-F97A-497B-ACA0-498CB23CBB85

Q31151637-CBEF0B3E-0825-43F1-AA20-4C1E411A83DC

Q31151637-D19184EE-53BF-430D-A2C4-447D9FFF1CB0

P2860

Q31151637-0CCE8046-0C74-4634-9994-CD1E329D15CF

Q31151637-0D18BAD3-B6EE-440C-897F-D932AA183AFB

Q31151637-0EB7748E-3D62-42EA-B00B-9EA2EBA1F8C5

Q31151637-2D30A481-564B-4E94-93AD-7F0D7AA2FE63

Q31151637-312DD62E-D647-45EC-B854-A4B31A34FCD5

Q31151637-532997F9-25C3-4D29-B711-1777A0B46277

Q31151637-6EC19329-FA45-4EF4-9FF1-ECDA1B68ECAC

Q31151637-7933B692-ABE1-4DFD-9FDC-18B7D63E8D1D

Q31151637-88702820-88E8-40E3-B02E-4D0FC27087E1

Q31151637-B2A1B3D4-718C-46DE-A9FD-AF3FDFAF81C7

P2888

Q31151637-380BD4DA-129D-4A6C-A350-A519E8B5A834

P304

Q31151637-AA7604D9-B425-4266-B9A1-C428F90B55DF

P31

Q31151637-1D1F256B-2E49-4D01-B989-F9BD593E564F

P356

Q31151637-ABCA1B56-ADD5-46F3-BC3B-86770DD4D47A

P407

Q31151637-4D3D6670-267E-4AB2-851B-CAAA7D45EBF5

P433

Q31151637-BC40BBA1-0B1D-40CA-8833-E7A56A2502C7

P478

Q31151637-4A4FC986-CCD3-4286-B477-EF21664C7C22

P50

Q31151637-C5A67432-A992-4B43-B9BD-BFEBE21EC0BC

P577

Q31151637-82B1FEAC-636E-4FE8-9090-D5D3BB463A31

P5875

Q31151637-E7618FA3-A14A-4DED-BFD3-05338E66B2B4

P6179

Q31151637-B5D53AE9-1032-46E5-9885-4D2EE723E661

P698

Q31151637-884CC7FE-0C9D-4C3C-9694-D5FAA14C6157

P932

Q31151637-76B3F256-3621-4BE7-B029-8925A0FF96D0

P356

P1433

British Journal of Cancer

P1476

Prevalence of type-specific HP ...... : data from the ARTISTIC trial

@en

P2093

A Bailey

http://www.w3.org/2001/XMLSchema#string

A Sargent

http://www.w3.org/2001/XMLSchema#string

A Turner

http://www.w3.org/2001/XMLSchema#string

ARTISTIC Study Group

http://www.w3.org/2001/XMLSchema#string

C Roberts

http://www.w3.org/2001/XMLSchema#string

C Thomson

http://www.w3.org/2001/XMLSchema#string

H C Kitchener

http://www.w3.org/2001/XMLSchema#string

J Mather

http://www.w3.org/2001/XMLSchema#string

M Almonte

http://www.w3.org/2001/XMLSchema#string

M Desai

http://www.w3.org/2001/XMLSchema#string

P2860

Sustained efficacy up to 4.5 years of a bivalent L1 virus-like particle vaccine against human papillomavirus types 16 and 18: follow-up from a randomised control trial

Prevalence of HPV infection among females in the United States

Epidemiologic classification of human papillomavirus types associated with cervical cancer

Human papillomavirus is a necessary cause of invasive cervical cancer worldwide

Classification of papillomaviruses

HPV testing in routine cervical screening: cross sectional data from the ARTISTIC trial

Enhanced detection and typing of human papillomavirus (HPV) DNA in anogenital samples with PGMY primers and the Linear array HPV genotyping test.

Cross-sectional comparison of an automated hybrid capture 2 assay and the consensus GP5+/6+ PCR method in a population-based cervical screening program.

Human papillomavirus type 16 sequence variation in cervical cancers: a worldwide perspective.

Comparison of linear array and line blot assay for detection of human papillomavirus and diagnosis of cervical precancer and cancer in the atypical squamous cell of undetermined significance and low-grade squamous intraepithelial lesion triage study

P2888

P304

1704-1709

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/SJ.BJC.6604324

http://www.w3.org/2001/XMLSchema#string

P407

P433

10

http://www.w3.org/2001/XMLSchema#string

P478

98

http://www.w3.org/2001/XMLSchema#string

P50

P577

2008-04-08T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

5460622

http://www.w3.org/2001/XMLSchema#string

P6179

1033382023

http://www.w3.org/2001/XMLSchema#string

P698

18392052

http://www.w3.org/2001/XMLSchema#string

P932

2391119

http://www.w3.org/2001/XMLSchema#string